164 related articles for article (PubMed ID: 23685895)
21. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
[TBL] [Abstract][Full Text] [Related]
22. [
Zhang X; Su X; Chen WC; Li Y; Yang ZY; Deng WZ; Deng TC; Yang AK
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):435-439. PubMed ID: 28635216
[No Abstract] [Full Text] [Related]
23. Immunohistochemical study of glypican 3 in thyroid cancer.
Yamanaka K; Ito Y; Okuyama N; Noda K; Matsumoto H; Yoshida H; Miyauchi A; Capurro M; Filmus J; Miyoshi E
Oncology; 2007; 73(5-6):389-94. PubMed ID: 18511877
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of clathrin promotes thyroid cell growth and contributes to multinodular goiter pathogenesis.
Lau ST; Zhou T; Liu JA; Fung EY; Che CM; Lang BH; Ngan ES
Biochim Biophys Acta; 2015 Aug; 1852(8):1676-86. PubMed ID: 25981745
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of expression of LGALS3BP gene in thyroid tissues and peripheral blood lymphocytes in patients with papillary thyroid cancer].
Kaliszewski K; Łukieńczuk T; Dobosz T; Rzeszutko M; Sadakierska-Chudy A
Endokrynol Pol; 2006; 57 Suppl A():38-44. PubMed ID: 17091455
[TBL] [Abstract][Full Text] [Related]
26. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
[TBL] [Abstract][Full Text] [Related]
27. Ghrelin and obestatin in thyroid gland - immunohistochemical expression in nodular goiter, papillary and medullary cancer.
Gurgul E; Kasprzak A; Blaszczyk A; Biczysko M; Surdyk-Zasada J; Seraszek-Jaros A; Ruchala M
Folia Histochem Cytobiol; 2015; 53(1):19-25. PubMed ID: 25765090
[TBL] [Abstract][Full Text] [Related]
28. Significance of IMP3, nucleophosmin, and Ki-67 expression in papillary thyroid carcinoma.
Yorukoglu A; Yalcin N; Avci A; Cakalagaoglu F; Yaylali G; Akin F; Haciyanli M; Ozden A
Int J Surg Pathol; 2015 Feb; 23(1):5-12. PubMed ID: 25389240
[TBL] [Abstract][Full Text] [Related]
29. MAGE-1, GAGE-1/-2 gene expression in FNAB of classic variant of papillary thyroid carcinoma and papillary hyperplasia in nodular goiter.
Ruschenburg I; Kubitz A; Schlott T; Korabiowska M; Droese M
Int J Mol Med; 1999 Oct; 4(4):445-8. PubMed ID: 10493989
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA‑744 suppresses cell proliferation and invasion of papillary thyroid cancer by directly targeting NOB1.
Liu H; Guo J; Chai H; Meng X
Mol Med Rep; 2019 Mar; 19(3):1903-1910. PubMed ID: 30628685
[TBL] [Abstract][Full Text] [Related]
31. Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma.
Wang JR; Li XH; Gao XJ; An SC; Liu H; Liang J; Zhang K; Liu Z; Wang J; Chen Z; Sun W
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):427-35. PubMed ID: 23467939
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of HIF-2α, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma.
Wang N; Luo HJ; Yin GB; Dong CR; Xu M; Chen GG; Liu ZM
Clin Dev Immunol; 2013; 2013():589423. PubMed ID: 24288553
[TBL] [Abstract][Full Text] [Related]
33. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
34. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
Qi H; Wang Y
Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
[TBL] [Abstract][Full Text] [Related]
35. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
36. Nuclear receptor expression in human differentiated thyroid tumors.
Mond M; Alexiadis M; Eriksson N; Davis MJ; Muscat GE; Fuller PJ; Gilfillan C
Thyroid; 2014 Jun; 24(6):1000-11. PubMed ID: 24559275
[TBL] [Abstract][Full Text] [Related]
37. Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer.
Stępień T; Brożyna M; Kuzdak K; Motylewska E; Komorowski J; Stępień H; Ławnicka H
Dis Markers; 2017; 2017():4962137. PubMed ID: 28255192
[No Abstract] [Full Text] [Related]
38. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ
Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539
[TBL] [Abstract][Full Text] [Related]
39. NOB1 in non-small-cell lung cancer: expression profile and clinical significance.
Liu K; Gu MM; Chen HL; You QS
Pathol Oncol Res; 2014 Apr; 20(2):461-6. PubMed ID: 24272676
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of NOB1 expression by RNAi inhibits cellular proliferation and migration in human gliomas.
Wang H; Li P; Zhao B
Gene; 2013 Oct; 528(2):146-53. PubMed ID: 23911301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]